SCHEMBL30768009

SCHEMBL30768009

COC(=O)c1ccc2occc(=O)c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 2/20 0.50
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
HSD17B10 Q99714 1/20 0.48
ACHE P22303 1/20 0.47
ROCK2 O75116 1/20 0.46
ROCK1 Q13464 1/20 0.46
CREBBP Q92793 1/20 0.46
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA7 P43166 1/20 0.45
XDH P47989 1/20 0.45
CA9 Q16790 1/20 0.45
CA14 Q9ULX7 1/20 0.45
MAOA P21397 4/20 0.44
MAOB P27338 4/20 0.44
TNKS O95271 1/20 0.44
MTNR1A P48039 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30768058 1.00 NQO2 (0.50) NQO2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL8784780 0.88 KDM4E (0.58) KDM4EALDH1A1HPGDHSD17B10ROCK2
SCHEMBL32670130 0.82 NPC1 (0.50) KDM4EACHEMAOAMAOBFTO
SCHEMBL30768028 0.80 TTR (0.51) ALDH1A1ACHEMAOAMAOBFTO
SCHEMBL6620745 0.80 TTR (0.51) ALDH1A1ACHEMAOAMAOBFTO
SCHEMBL826046 0.79 HTR1B (0.59) KDM4EALDH1A1HPGDHSD17B10CREBBP
SCHEMBL30768023 0.79 HTR1A (0.51) NQO2KDM4EACHEMAOAMAOB
SCHEMBL1874005 0.79 HTR1A (0.51) NQO2KDM4EACHEMAOAMAOB
SCHEMBL19740390 0.78 NQO2 (0.56) NQO2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL30768019 0.78 MAOA (0.43) KDM4EALDH1A1HPGDACHEMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117615763-A Phosphoinositide 3 kinase beta inhibitor, composition and preparation method thereof 健道生物医药有限公司 2024-02-27 CN disclosed